Navigation Links
Lymphoma Research Foundation Annual Gala Raises Nearly $1 Million For Research and Support Services
Date:10/5/2017

The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – held its Annual Gala, Powered by Innovation, at the historic Plaza Hotel in New York City on Wednesday, September 27, 2017. The 2017 Annual Gala raised $926,105 in support of LRF’s research programs and support services.

Each year, the Lymphoma Research Foundation recognizes the efforts of several key partners for their contributions to advancing LRF’s critical mission of eradicating lymphoma and serving those touched by this disease. Bristol-Myers Squibb was recognized for its forward-looking vision in the field of immunotherapy with the 2017 Corporate Leadership Award. This year’s Distinguished Service Award was bestowed upon Nancy and Oliver W. Press, MD, PhD, while LRF volunteer Ben Haines was named this year’s recipient of the Freundlich Leadership Award in appreciation of his work as a patient-advocate.

“We greatly value our continued collaboration with the Lymphoma Research Foundation to support patients, and we appreciate receiving this award in recognition of our efforts to accelerate research and develop novel treatments that we hope will make a true difference in the lives of people diagnosed with lymphoma,” said Awny Farajallah, MD, Vice President, Head of US Medical Oncology at Bristol-Myers Squibb. “All of our work at Bristol-Myers Squibb is 'Powered by Innovation,' and we are thankful to have partners like the Lymphoma Research Foundation who share this motivation.”

Guests and honorees at this year’s Gala were encouraged to wear red in recognition of Blood Cancer Awareness Month (BCAM), held each year during the month of September to raise funds and awareness for blood cancer. Culminating with the 2017 Annual Gala, this year’s BCAM saw more than 100 buildings light red as a part of LRF’s Light it Red for Lymphoma initiative.

“Today, the number of people in the United States living with a form of lymphoma has risen to just over one million,” said Meghan Gutierrez, LRF Chief Executive Officer. "As this number continues to grow, events like this evening's gala become even more critical to addressing the needs of the lymphoma community, by raising the funds necessary to support LRF’s research program and patient support services."

For more information on the evening’s success and to support the Lymphoma Research Foundation’s Gala, visit lymphoma.org/gala.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $60 million in lymphoma-specific research.

For additional information on LRF’s research, education and services, visit lymphoma.org.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14773680.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. MedMar Healing Center Co-founder Rafael Hernandez Goes the Distance for Leukemia and Lymphoma Society, Running Three Marathons for Nonprofit Health Organization
2. Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells
3. Scientists explore promising new option for first line of attack in lymphoma
4. Chemo-free treatment a possibility for leukemia/lymphoma
5. Increased risk of relapse omitting RT in early PET scan negative Hodgkin lymphoma
6. Inhibition of CDK4 might promote lymphoma development and progression
7. New drug for non-Hodgkin lymphoma and chronic lymphocytic leukemia passes early test
8. MRI catches breast cancer early in at-risk survivors of childhood Hodgkin lymphoma
9. Hepatitis C reactivation doesnt worsen survival for HIV+ patients diagnosed with lymphoma
10. Identification of central nervous system involvement for patients with AIDS-related lymphomas
11. Combination therapy may help patients with follicular lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: